Edessa scores 76/100 (grade C, ranked #73) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
A Florida telehealth that names all four of its compounding pharmacies and now sells brand-name Ozempic and Zepbound alongside compounded injections, but leads with a half-price first month.
Tryozi matches Edessa at 76/100; our Tryozi ruling in full has the pricing conditions and the caveats in detail.
Zera Health is a telehealth platform for compounded GLP-1 weight loss — semaglutide from $149/mo, tirzepatide from $199/mo, plus oral and low-dose microdose options — prescribed by licensed physicians in…
Zera Health scores 77/100 to Edessa's 76; our Zera Health ruling in full has the pricing conditions and the caveats in detail.
Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
Claya scores 75/100 to Edessa's 76; our Claya ruling in full has the pricing conditions and the caveats in detail.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.